Showing results (531-540 of 857) with videos related to
Sort By:
Pageof 86
The American Journal of Pathology|May 28, 2013
Angiotensin II contributes to diabetic renal dysfunction in rodents and humans via Notch1/Snail pathwayElena Gagliardini, Norberto Perico, Paola Rizzo, et al.Diabetologia|April 2, 2017
MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathyCristina Zanchi, Daniela Macconi, Piera Trionfini, et al.Journal of the American Society of Nephrology : JASN|February 3, 2023
Intensive BP Control in Patients with CKD and Risk for Adverse OutcomesElaine Ku, Charles E McCulloch, Lesley A Inker, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2023
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort StudyPiero Ruggenenti, Linda Reinhard, Barbara Ruggiero, et al.Journal of the American Society of Nephrology : JASN|March 26, 2015
Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous NephropathyPiero Ruggenenti, Hanna Debiec, Barbara Ruggiero, et al.Journal of the American Society of Nephrology : JASN|June 24, 2003
Add-on anti-TGF-beta antibody to ACE inhibitor arrests progressive diabetic nephropathy in the ratAriela Benigni, Carla Zoja, Daniela Corna, et al.Hypertension (Dallas, Tex. : 1979)|January 28, 2004
L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant speciesMarina Noris, Marta Todeschini, Paola Cassis, et al.Tissue Engineering. Part A|December 11, 2013
Recellularization of well-preserved acellular kidney scaffold using embryonic stem cellsBarbara Bonandrini, Marina Figliuzzi, Evangelia Papadimou, et al.American Journal of Physiology. Renal Physiology|August 6, 2011
Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetesCarla Zoja, Sara Cattaneo, Fabio Fiordaliso, et al.Eclinicalmedicine|January 10, 2022
Nephrotic-range proteinuria in type 2 diabetes: Effects of empagliflozin on kidney disease progression and clinical outcomesPiero Ruggenenti, Bettina J Kraus, Silvio E Inzucchi, et al.Pageof 86